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Purpose: The purpose of this study is to evaluate the utility of using continuous heart rate variability
(HRV) and respiratory rate variability (RRV) monitoring for (a) tracking daily organ dysfunction in
critically ill patients and (b) identifying patterns of variability changes during onset of shock and
resolution of respiratory failure.
Materials and Methods: Thirty-three critically ill patients experiencing respiratory and/or cardiac failure
underwent continuous recording of their electrocardiogram and capnogram (CO2) waveforms from
admission or intubation until discharge (maximum 14 days). HRV and RRV were computed in 5-minute
overlapping windows, using Continuous Individualized Multi-organ Variability Analysis software.
Multiple organ dysfunction scores were recorded daily. HRV and RRV trajectories were characterized
during onset of shock and resolution of respiratory failure.
Results: Both HRV and RRV decreased with increasing severity of multiple organ dysfunction scores
for a variety of variability metrics. A decline in several measures of HRV and no decline in RRV were
observed before onset of shock (n = 6). In contrast, during resolution of respiratory failure, an increase
in RRV was observed in patients who successfully passed extubation (n = 12), with no change in RRV
in those who subsequently failed extubation (n = 2).
Conclusions: There is an association between reduced HRV and RRV and increasing organ dysfunction
in critically ill patients. The significance of observing trends of decreasing HRV (with onset of shock)
and increasing RRV (with resolution of respiratory failure) merits further investigation.
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Prognostication of severity of illness has long been a
subject of investigation by intensivists and scientists. Several
sophisticated scoring systems exist, which “quantify the
generic severity of illness early during the course of the
intensive care unit (ICU) stay and express that severity as a
probability of survival for a given patient” [1]. Such tools (e.g,
references [2-4]) are very important for the initial evaluation
and planning of a course of care. However, their usefulness is
reduced when trying to foretell what will happen to an
individual patient in the ICU, for example, if they will develop
new organ dysfunction or if they are responding to a given
therapy [1]. Organ dysfunction scores such as the multiple
organ dysfunction syndrome (MODS) score [5] and sequential
organ failure assessment (SOFA) score [6] are objective
measures of a patient's severity of illness and offer simpli-
fication to the complexity of their current physiologic state.
Those measures, if monitored daily and compared against a
baseline value at the time of admission or aggregated over the
course of ICU stay, can offer additional insight into clinical
deterioration or improvement [1,7,8].
Complex systems science has been hypothesized to
provide a complementary approach for the description and
management of organ dysfunction in the critically ill patient
[9]. Clinically valuable information, hidden within the
rhythms of the body, can be uncovered by advanced tech-
niques rooted in mathematical physics and nonlinear
dynamics. For example, electrocardiogram (ECG) and cap-
nogram waveforms may be used to measure heart rate
variability (HRV) and respiratory rate variability (RRV), de-
rived from the time series of interbeat and interbreath inter-
vals. Numerous studies reviewed previously [10] demonstrate
how these time series are characterized by specific patterns
that can be used to discriminate between healthy and pathol-
ogic patients and demonstrate that degree of variability cor-
relates with illness severity.
Focusing on critically ill patients, the clinical significance of
reduced HRVwas demonstrated in association with sepsis and
septic shock [11-13] and the evaluation of its severity [14,15].
Moreover, HRV analysis has shown prognostic capabilities in
adult septic patients as an early marker of MODS [16] and an
early predictor of death in emergency departments [17].
Considering pediatric applications, alteredHRVwas present in
children developing sepsis or septic shock [18] and correlated
with illness severity and organ dysfunction in pediatric ICU
patients [19,20]. Similarly, the clinical significance of altered
respiratory variability has been demonstrated in the detection
of respiratory dysfunction associated with asthma [21-23],
sleep apnea [24], and panic disorder [25-27]. In the ICU, recent
investigations have focused on respiratory variability as a
novel predictor of successful weaning of patients from
mechanical ventilation [28-33].
The value of tracking variability over time was demon-
strated in noncritically ill patients by Voss [34], whoconducted HRV studies in pregnant women and athletes
spanning weeks and months. In the ICU setting, however,
the potential for improving individualized patient care
through variability monitoring remains largely unexplored.
This is primarily due to challenges associated with the
continuous acquisition, transfer, and analysis of physiologic
waveforms from patient monitoring systems [35]. For this
reason, most prior studies have assessed HRV for short
intermittent epochs of 5 to 15 minutes. Among the few
focusing on longitudinal analysis of variability in the ICU,
Papaioannou et al [36] evaluated daily variability over the
course of a patient's ICU stay, correlating HRV with mor-
tality and organ dysfunction (as estimated by daily SOFA
score), and Kasaoka et al [37] pursued real-time
HRV monitoring in the ICU, performing analyses of vari-
ability over 2 different conditions (mechanical vs spontane-
ous breathing and response to shock). Recently, in this
journal, we presented a study describing a methodology and
reported on the feasibility of continuous simultaneous HRV
and RRV monitoring in critically ill patients [38] using
Continuous Individualized Multiorgan Variability Analysis
(CIMVA), a software tool developed by our group for
continuous variability monitoring [39].
In the present study, we sought to combine continuous
multiorgan waveform acquisition with longitudinal variabil-
ity analysis and relate this novel information stream with
patient status (e.g, MODS score) and outcomes (e.g., onset of
shock and resolution of respiratory failure). We hypothesized
that continuous variability monitoring in the ICU can pro-
vide improved ability to predict clinical improvement or
deterioration (ie, detect clinical trajectory), potentially
leading to real time prognostication in this critical care
setting. The overall aims of this study were to explore the
feasibility of using CIMVA in an ICU setting to (1) evaluate
the association between daily MODS scores and daily
measures of HRV and RRV and (2) evaluate the pattern of
variability changes as a predictor of the onset of shock (i.e,
initiation of vasopressors) and resolution of respiratory
failure (ie, extubation).2. Materials and methods
2.1. Patients
2.1.1. Enrollment
The study was performed in the 32-bed ICU of a single
tertiary care hospital (Ottawa General Hospital). The patient
population in the unit can be characterized as combined
medical/surgical (no trauma). Critically ill patients exper-
iencing respiratory and/or cardiac failure were selected to
have their ECG and capnogram (CO2) waveforms continu-
ously recorded while in the ICU. Thirty-three patients were
enrolled between June 2009 and November 2009.
1 The data acquisition system provided an ECG waveform of 125 Hz,
which is less than the native resolution (1000 Hz) of the patient monitor.
However, this system also provided beat annotations harvested simulta-
neously that were calculated using the higher resolution (ie, the RRI time
series had a time resolution of 0.001 s, not 0.008 s).
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This study was approved by the Ottawa Hospital Re-
search Ethics Board. Waived consent was obtained as the
study was observational, data were de-identified, and we
wished to eliminate the potential for bias and limitations to
external validity.
2.1.3. Inclusion criteria
Patients admitted to ICU within 48 hours with respiratory
and/or cardiac failure and expected period on study greater than
72 hours were included. Respiratory failurewas defined as the
need for mechanical ventilation and a PaO2/fraction of inspired
oxygen less than 300. Cardiac failure was defined as hypo-
tension requiring 2 or more consecutive hours of vasopressors
(norepinephrine or epinepherine N5 μg/kg per minute,
phenylephrine N50 μg/min, or vasopressin N0.03 U/min).
2.1.4. Exclusion criteria
Patients with chronic atrial fibrillation (determined from past
medical history reported by the patient/family to the treating
team) and/or transferred from another ICU were excluded.
2.2. Clinical data collection
The following parameters were recorded for each patient
once (upon enrollment into the study): demographic informa-
tion, ICU admission diagnosis, comorbidities, and Acute Phy-
siology and Chronic Health Evaluation II score on the day of
admission. Other parameters recorded throughout the study
included date and time of extubation, total length of stay (if
within 30 days), survival status in ICU and at 30 days after ICU
admission, need for reintubation, and need for tracheostomy.
The following parameters were recorded daily for each
patient: MODS scores, ventilator settings, presence and
dosages of inotropes, and/or vasopressors.
2.3. Waveform data collection
Continuous ECG and capnogram waveforms (125 Hz)
were captured from Philips IntelliVue MP70 monitors as
described previously [38]. Electrocardiographic monitoring
was initiated within 36 hours of ICU admission and con-
tinued until ICU discharge or a maximum of 14 days; CO2
monitoring was initiated when Philips IntelliVue CO2 mea-
surement modules were applied at time of enrollment and
continued until extubation or a maximum of 14 days.
2.4. Continuous Individualized Multi-organ
Variability Measurement processing
Continuous Individualized Multi-organ Variability Mea-
surement software was used to generate continuous HRV
and RRV time series for each patient, a process that has
been described in detail previously [38]. Briefly, the follow-
ing data processing stages are performed over continuouswindows of time: (1) automatic beat detection1 and breath
detection, (2) creation of R-R interval (RRI) time series and
interbreath interval time series, (3) identification of atrial
fibrillation (ECG only), (4) identification and elimination of
artifact and outliers, (5) variability analysis, and (6) post-
processing to remove poor quality windows. The CIMVA
analysis was performed with a sliding window length of 5
minutes (50% overlap between adjacent windows) through-
out the duration of the input RRI and interbreath interval
time series data. This resulted in continuous HRV and RRV
outputs at a sampling interval of 2.5 minutes. A wide panel
of variability measures was calculated, including those from
time domain, frequency domain, time-frequency domain,
entropy domain, and scale-invariant domain [38]. Frequency
domain measures are not reported for RRV.
2.5. Analysis of CIMVA variability output
Any patient who experienced intermittent episodes of
atrial fibrillation or other arrhythmias (eg, trigeminy,
bigeminy) during the study period were excluded from all
HRV analyses but included in RRV analyses.
2.5.1. Analysis of variability in association with
organ dysfunction
Variability metrics (calculated as the average of all
5-minute CIMVA analysis windows in a day, from midnight
to midnight) were computed for each day of each patient's
ICU stay. In order for a patient-day to be included in the
analysis, the following criteria had to be met: (a) at least
80% of the 5-minute CIMVA analysis windows had to
survive the postprocessing quality filter and (b) the MODS
score for a given patient-day had to be composed of at least
2 of the 6 constituent organ system scores (cardiovascular,
respiratory, hematologic, liver, renal, and neurological). All
patient-days meeting these criteria were then categorized by
severity of organ dysfunction recorded on that day as
follows: low MODS (0-2 inclusively), medium MODS (3-7
inclusively), or high MODS (N7). Within the patient-days in
each category, the variability values were averaged.
2.5.2. Statistical analysis
For each variability measure, the Kruskal-Wallis test
(nonparametric analysis of variance [ANOVA]) was used to
compare the medians among low, medium, and high MODS.
For those measures rejecting the null hypothesis of equal
median among the 3 groups, a post hoc analysis was per-
formed using the Wilcoxon 2-sided rank sum test, to test
the equality between the medians of each pair of groups. In
particular, for each variability measure, the statistical test was
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(ii) medium MODS vs high MODS, and (iii) low MODS vs
high MODS. The P values reported for each test represent
the probability of observing the given result by chance if the
null hypothesis is true. An α value of .05 was used to
determine statistical significance. When reporting the results
of multiple statistical tests (one for each variability measure
—24 for HRV and 20 for RRV), one must pay particular
attention to multiple comparison testing and the possibility of
false positives (ie, those measures that report a meaningful
association when in fact none exists). To address this, we
used the false discovery rate (FDR) method of Benjamini
and Yekutieli [40] with a rate of 0.05.
2.5.3. Trajectory of variability before onset of shock
and extubation
We wished to investigate the time trajectory of variability
in patients who experienced onset or resolution of organ
failure. We elected to focus on (a) shock episodes, defined
by initiation of vasopressors (an example of organ failure
onset), and (b) extubation (an example of organ failure
resolution). Individual patient HRV and RRV trajectories
were summarized averaging the 5-minute variability win-
dows over nonoverlapping 2-hour periods leading up to and
continuing after the event of interest (for a total of 18 hoursFig. 1 Box plot of daily HRV and MODS severity. Low (MODS 0-2; n
N7; n = 32 days). In each plot, the central mark is the median, the box edg
the most extreme data points not considered as outliers.before the event of interest). The mean across all included
patients at each point (Δt = 2 hours) was then computed. In
the case of shock, HRV data were reported for an additional
6 hours after shock onset.
3. Results
3.1. Demographic data
In total, 33 patients were enrolled in the study. Demo-
graphic information for these patients is provided in Bradley et
al [38]. At the onset ofmonitoring, themost common pattern of
organ failure was simultaneous respiratory and cardiac failure
(n = 23), compared with just respiratory (n = 7) or just cardiac
(n = 3) failure. Mean number of days enrolled in the study was
11.0 (±3.6). Seven patients died within the 14-day monitoring
period, and another 3 died within 30 days (30-day mortality
rate of 30.3%).
3.2. Analysis of variability in association with
organ dysfunction
In total, 189 days of patient ICU data was included in the
HRV analysis, with low, medium, and high MODS= 51 days), medium (MODS 3-7; n = 106 days), and high (MODS
es are the 25th and 75th percentiles, and the box whiskers extend to
Fig. 2 Box plot of daily RRV andMODS severity. Low (MODS 0-2; n = 38 days), medium (MODS 3-7; n = 92 days), and high (MODS N7;
n = 44 days). In each plot, the central mark is the median, the box edges are the 25th and 75th percentiles, and the box whiskers extend to the
most extreme data points not considered as outliers.
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tively. One hundred seventy-four days were included in the
RRV analysis, with low, medium, and high MODS categ-
ories consisting of 38, 92, and 44 days, respectively. Mean
daily HRV and RRV were generally higher on days with low
MODS scores (least sick patients) compared with days with
medium or high MODS scores (sickest patients), as shown in
Figs. 1 and 2 for selected measures of HRV and RRV,
respectively. The summaries of HRV and RRV measures are
shown in Table 1 and Table 2, along with the results of the
nonparametric ANOVA tests (and where applicable, Wil-
coxon rank sum tests).
3.2.1. Heart rate variability and organ failure
For several measures of HRV (10/24; see Table 1), sig-
nificant differences were observed in mean daily variability
between the MODS categories. Considering this subset of
measures, 8 of 10 tests rejected the null hypothesis of equal
medians in distinguishing low vs medium MODS, 4 of 10
tests rejected the null hypothesis of equal medians in distin-
guishing medium vs high MODS, and 10 of 10 tests rejected
the null hypothesis of equal medians in distinguishing low vs
high MODS. For the original nonparametric ANOVA test,
when adjusted for FDR of 5%, 5 of 24 variability measures
remained significant (using an adjusted P = .0024)—coefficient of variation, power law y-intercept (frequency-
based), detrended fluctuation analysis (DFA) α (overall), DFA
α2, and Poincare SD2.
3.2.2. Respiratory rate variability and organ failure
A few significant differences between the MODS categ-
ories were observed in mean daily RRV (5/20; see Table 2).
Considering this subset of measures, 4 of 5 tests rejected the
null hypothesis of equal medians in distinguishing low vs
medium MODS, 0 of 5 tests rejected the null hypothesis of
equal medians in distinguishing medium vs high MODS,
and 5 of 5 tests rejected the null hypothesis of equal medians
in distinguishing low vs high MODS. For the original non-
parametric ANOVA test, when adjusted for FDR of 5%, 1 of
20 variability measures (skewness) remained significant
(using an adjusted P = .000575).
3.3. Trajectory of variability before onset of shock
and extubation
3.3.1. Onset of shock
Six patients who experienced shock had valid data for
HRV analysis (ie, 18 hours of heart rate monitoring before
onset of shock). As shown in Fig. 3, there was a declining
trajectory of HRV before the onset of shock and an observed
Table 1 Daily HRV results for patient-days with low, medium, and high MODS
HRV (units) L MODS (0-2) M MODS (3-7) H MODS (N7) P value for
ANOVA test
Wilcoxon rank sum P values
n = 51 n = 106 n = 32 L-M M-H L-H
Median IQR Median IQR Median IQR
Mean (s) 0.66 0.599-0.72 0.624 0.568-0.727 0.637 0.579-0.694 .457 NA NA NA
SD (s) 0.0102 0.00788-0.0143 0.00797 0.00552-0.0124 0.00614 0.0037-0.0108 .004 .00774 ⁎ .106 .00715 ‡
RMSSD (s) 0.00539 0.00382-0.00692 0.00472 0.00325-0.0069 0.00441 0.0032-0.0068 .415 NA NA NA
Skewness (none) 0.0344 −0.132-0.238 −0.0129 −0.218-0.156 −0.0907 −0.255-0.001 .054 NA NA NA
Kurtosis (none) 3.82 3.41-4.93 4.15 3.53-5.9 5.2 3.91-7.75 .015 .163 .0444 † .00346 ‡
CV (none) 0.0163 0.0112-0.0208 0.0118 0.009-0.0163 0.01 0.0072-0.0145 b .001 a .00379 ⁎ .0266 † .000333 ‡
Power law slope—frequency based −0.104 −0.145 to −0.064 −0.0964 −0.145 to −0.0576 −0.0992 −0.136 to −0.0394 .765 NA NA NA
Power law y-intercept—frequency
based (s2/log Hz)
3.1 2.75-3.32 2.76 2.34-3.15 2.61 1.98-3.03 .001 a .00278 ⁎ .132 .000852 ‡
Power law x-intercept—frequency
based (log Hz)
12.1 −9.46-26.2 4.91 −5-19.3 4.94 −3.78-17.8 .402 NA NA NA
Power law slope—histogram based −0.634 −0.661 to −0.596 −0.653 −0.718 to −0.609 −0.696 −0.748 to −0.607 .022 .0344 ⁎ .21 .012 ‡
Power law y-intercept—histogram
based (none)
−4.38 −4.58 to −4.15 −4.57 −4.99 to −4.24 −4.74 −5.18 to −4.33 .004 .0104 ⁎ .14 .00225 ‡
Power law x-intercept—histogram
based (log s)
−7.25 −7.42 to −6.91 −7.15 −7.39 to −6.92 −7.13 −7.34 to −6.86 .722 NA NA NA
DFA AUC (none) −2.82 −3.08 to −2.63 −3.03 −3.31 to −2.72 −3.13 −3.54 to −2.72 .025 .0165 ⁎ .317 .0374 ‡
DFA α overall (none) 1.16 1.05-1.24 1.1 1.02-1.19 1.05 0.929-1.12 .002 a .066 .0139 † .000974 ‡
DFA α 1 (none) 1.04 0.799-1.26 0.981 0.784-1.18 0.957 0.7-1.11 .384 NA NA NA
DFA α 2 (none) 1.16 1.03-1.23 1.08 0.971-1.17 1.02 0.926-1.1 b .001 a .0282 ⁎ .00649 † .000127 ‡
Approximate entropy (none) 0.981 0.931-1.03 0.997 0.934-1.06 1.02 0.955-1.12 .120 NA NA NA
Sample entropy (none) 1.46 1.31-1.71 1.57 1.44-1.8 1.58 1.35-1.8 .088 NA NA NA
LF/HF ratio (none) 2.29 1.17-4.16 2.29 1.15-3.86 1.73 0.957-3.91 .546 NA NA NA
LF power (n.u.) 18.3 5.91-31.2 9.23 4.28-25.5 8.58 2.93-28.1 .246 NA NA NA
HF power (n.u.) 7.97 4.31-18.4 5.98 3.12-12.5 5.67 2.96-13 .263 NA NA NA
Wavelet AUC (none) −35.5 −37.8 to −32.7 −37.2 −41.5 to −33.3 −37.6 −43.1 to −32.8 .077 NA NA NA
Poincare SD1 (none) 3.82 2.71-4.9 3.34 2.3-4.88 3.12 2.27-4.8 .419 NA NA NA
Poincare SD2 (none) 13.7 9.93-19.5 10.8 7.15-16.2 8.34 4.74-13.6 .002 a .00662 ⁎ .0868 .00247 ‡
Median and interquartile range are shown. For each measure, results of nonparametric ANOVA test are shown. Where the null hypothesis of equal median among the L, M, and H groups are rejected (P b .05), a
post hoc Wilcoxon rank sum test was run to test for equality between groups pairs (low-medium, medium-high, and low-high). n indicates the number of days; L, low; M, medium; H, high; IQR, interquartile
range; NA, not applicable; AUC, area under curve.
a Measures that remained significant after adjustment for the FDR are indicated.
⁎ P b .05 was deemed to be statistically significant between low and medium.
† P b .05 was deemed to be statistically significant between medium and high.
‡ P b .05 was deemed to be statistically significant between low and high.
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Table 2 Daily RRV results for patient days with low, medium, and high MODS
RRV (units) L MODS (0-2) M MODS (3-7) H MODS (N7) P value for
ANOVA test
Wilcoxon rank sum
P values
n = 38 n = 92 n = 44 L-M M-H L-H
Median IQR Median IQR Median IQR
Mean (s) 3.5 2.95-3.99 3.35 2.82-4.03 3.41 2.94-4.37 .735 NA NA NA
SD (s) 0.589 0.431-0.938 0.494 0.275-0.863 0.485 0.33-0.684 .149 NA NA NA
RMSSD (s) 0.746 0.488-1.21 0.643 0.347-1.13 0.592 0.431-0.917 .293 NA NA NA
Skewness (none) 0.664 0.255-0.996 0.319 0.0885-0.826 0.195 −0.0284-0.38 .001 a .0147 ⁎ .0533 .0000676 ‡
Kurtosis (none) 4.3 3.69-5.08 4.59 3.41-5.7 3.74 3.33-5.36 .184 NA NA NA
CV (none) 0.18 0.132-0.254 0.152 0.0956-0.234 0.125 0.0948-0.177 .035 .0805 .292 .00617 ‡
Power law slope—frequency based 0.105 0.0499-0.14 0.129 0.0671-0.173 0.0933 0.0388-0.175 .111 NA NA NA
Power law y-intercept—frequency
based (s2/log Hz)
6.55 6.27-7.07 6.31 4.89-6.91 6.3 5.49-6.7 0.084 NA NA NA
Power law x-intercept—frequency
based (log Hz)
−15.1 −60.4-17.3 −16.4 −47.4-27.1 −11.1 −33.7-44.7 .535 NA NA NA
Power law slope—histogram based −0.288 −0.317 to −0.254 −0.306 −0.407 to −0.233 −0.265 −0.332 to −0.223 .166 NA NA NA
Power law y-intercept—histogram
based (none)
−1.98 −2.16 to −1.85 −2.04 −2.52 to −1.85 −2.01 −2.25 to −1.88 .341 NA NA NA
Power law x-intercept—histogram
based (log s)
−7.9 −8.49 to −6.07 −7.34 −9.2 to −6.09 −8.8 −9.66 to −6.7 .265 NA NA NA
DFA AUC (none) −0.325 −0.452 to −0.169 −0.427 −0.789 to −0.18 −0.361 −0.61 to −0.224 .288 NA NA NA
DFA α overall (none) 0.668 0.567-0.784 0.59 0.464-0.687 0.596 0.431-0.669 .009 .00499 ⁎ .746 .00653 ‡
DFA α 1 (none) 0.708 0.582-0.824 0.6 0.491-0.729 0.606 0.435-0.707 .012 .00897 ⁎ .525 .0071 ‡
DFA α 2 (none) 0.487 0.284-0.578 0.37 0.183-0.485 0.338 0.146-0.496 .042 .0283 ⁎ .572 .0224 ‡
Approximate entropy (none) 0.521 0.44-0.573 0.533 0.416-0.607 0.463 0.349-0.557 .133 NA NA NA
Wavelet AUC (none) −3.4 −4.86 to −1.41 −4.36 −10.3 to −1.32 −3.64 −7.17 to −1.89 .342 NA NA NA
Poincare SD1 (none) 531 347-864 458 247-807 421 307-653 .297 NA NA NA
Poincare SD2 (none) 619 466-1000 553 270-894 537 328-684 .091 NA NA NA
Median and interquartile range are shown. For each measure, results of nonparametric ANOVA test are shown. Where the null hypothesis of equal median among the low, median, and high groups are rejected (P
b .05), a post hoc Wilcoxon rank sum test was run to test for equality between groups pairs (low-medium, medium-high, and low-high). n indicates the number of days.
a Measures that remained significant after adjustment for the FDR are indicated.
⁎ P b .05 was deemed to be statistically significant between low and medium.
‡ P b .05 was deemed to be statistically significant between low and high.
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Fig. 3 Mean (±SEM) HRV trajectories encompassing 18 hours before and 6 hours after onset of shock (t = 0). Mean HRV (averaged
5-minute variability windows) for each 2-hour period plotted for all patients (n = 6).
879.e8 G.C. Green et al.rise in HRV after the onset of shock (averaged across all
patients). Respiratory rate variability was also analyzed for 6
patients. As shown in Fig. 4, there was no obvious decline in
RRV as early as 18 hours before shock; however, a slight
downwards trend was observed between 12 and 6 hours
before the onset of shock. A rise in variability post onset of
shock was also observed for RRV.
3.3.2. Resolution of respiratory failure
Twelvepatientswhowereextubatedwhileonstudyhadvalid
data for the HRV analysis. Of these, 9 extubations were
successful, and3extubations failed.As shown inFig.5, patients
whopassedextubationhadhigherHRVonaverageleadingupto
and after extubation. Respiratory rate variability was analyzed
for 14 extubations—12 successful and 2 failed. As shown in
Fig. 6, patients who passed extubation experienced a steady
increase in RRV starting between 10 and 8 hours before
extubation compared with those who failed, where RRV was
either steady or slightly declining in this same period.
Respiratory rate variability measured by SD for patients with
successful extubations was higher on average during the 18Fig. 4 Mean (±SEM) RRV trajectories encompassing 18 hours befor
5-minute variability windows) for each 2-hour period plotted for all patihours leading up to extubation, but this observation is not as
prominent with the other variability measures.4. Discussion
The main objective of this exploratory study was to
perform an observational analysis of both HRV and RRV
monitoring in conjunction with daily measures of organ
failure for critically ill patients. The results demonstrated an
association between reduced HRV and RRV and organ
dysfunction in critically ill patients, that is, HRV and RRV
tend to be higher on days with low MODS scores compared
with days with medium or high MODS scores. For patients
undergoing monitoring around shock and extubation, several
measures of HRV and RRV showed distinct trajectories
beginning 12 to 18 hours beforehand.
Several studies have reported reduced variability in asso-
ciation with MODS, particularly with measures reflecting
autonomic nervous activity [41]. Although we havee and 6 hours after onset of shock (t = 0). Mean RRV (averaged
ents (n = 6).
Fig. 5 Mean (±SEM) HRV trajectories encompassing 18 hours before and 6 hours after extubation (t = 0). Mean HRV (averaged 5-minute
variability windows) for each 2-hour period plotted for all patients (n = 12 patients are included: 9 successful, 3 failed).
879.e9Continuous multiorgan variabilty analysiscompared with MODS scores according to 3 categories of
illness severity rather than 2 (eg, as in Papaioannou et al
[36]), our results are consistent for SD and LF/low frequency
to high frequency ratio (LF/HF)HF when comparing the low
MODS and high MODS groups. They are not consistent,
however, for approximate entropy (ApEn) which we found
to be lower in less severely ill patients. It is possible that
entropy measures, which have demonstrated effectiveness as
a predictor of mortality [42], are sensitive to factors for
which we did not control (eg, time of day of measurement,
body position, medications, etc). We did observe higher
ApEn on days with lower MODS when analyzing RRV,
although the results were not statistically significant. There
were no studies that we could find with which to compare
RRV results in association with MODS.
For patients who experienced cardiac shock, the trajectory
of several measures of HRV showed a downwards trend
beginning as early as 18 hours before the onset of shock, with
minimums occurring approximately 2 to 4 hours before the
onset of shock. In general, HRV appears to outperform RRV
as an indicator of onset of shock. The rise in HRV and RRV
slightly before and following the onset of shock could be due
to interventions initiated to treat the symptoms of the im-
pending shock. We could identify no studies with which toFig. 6 Mean (±SEM) RRV trajectories encompassing 18 hours before
variability windows) for each 2-hour period plotted for all patients (n =compare these results (ie, a trajectory of variability leading
up to the onset of shock), but our findings are consistent with
those studies, which showed an association between septic
shock and reduction of HRV [11,13]. Lastly, we have pre-
viously demonstrated loss of HRV in association with the
onset of clinical diagnosis of infection in ambulatory non-
critically ill patients, occurring on average 24 hours before
clinical diagnosis [39].
In this study, we found that, for patients who experienced
successfulextubation, thetrajectoryofseveralmeasuresofRRV
showed an upwards trend beginning as early as 10 hours before
the extubation. Sedation is known to affect biosignal variability
in critically ill patients [43]—the extent to which decreasing
sedationbeforethespontaneousbreathingtrialaccountedfor the
increased respiratory variability in this group remains unclear.
For the entire 18 hours analyzed, HRV values were on average
higher for those patientswhowere successfully extubated com-
pared with those who failed; however, no obvious upwards or
downwards trend was observed for either group.
There are several limitations to this pilot study. The
association between increasing organ failure and reducedHRV
and RRV is based on a retrospective separation of patient-days
into 3 groups of organ failure. It is important to note that the
aggregated pool of patient-days (n = 189 for HRV and n = 174and 6 hours after extubation (t = 0). Mean RRV (averaged 5-minute
14 patients are included: 12 successful, 2 failed).
879.e10 G.C. Green et al.for RRV) included multiple days from the same patient. Thus,
as a patient's MODS score changed throughout their ICU stay,
patient-days for the same patient would have appeared in all
MODS categories—high, medium, and low.
Lastly, an important caveat to bear in mind is that these
preliminary results are reported on population-based averages
and are not intended to imply that the patterns in vital sign
variability seen in this study are “signatures” of various events
in individual patients. The tracking of variability in individual
patients proved challenging due to numerous confounding
factors affecting variability, most notably sedation and inter-
ventions. Rather, these findings suggest a potential value in
tracking cardiorespiratory variability over time, which merits
further investigation. The small numbers of this investigation
preclude a conclusive analysis, but rather serve to support
hypotheses and prior literature linking reduced variability
occurring in association with critical illness.5. Conclusions
In this pilot study, for the first time, we have demonstrated
that tracking both HRV and RRV over time with CIMVA
offers a potential means to characterize severity of organ
dysfunction on a daily basis. The loss of HRV before onset of
shock and the rise in RRV before successful resolution of
mechanical ventilation further support the potential utility of
multiorgan variability monitoring to characterize a patient's
physiologic responses to clinical events. No additional
invasive monitor was required for this analysis, rather the
results stem simply from a more efficient use of all data
harvested at the bedside. This allows for the analysis of
variability at any specific point in time or the analysis of data
over time, so that deterioration can be tracked by visual
inspection of the signals [11,13,37]. Taken together, these
results support the assertions made by Voss [34], who noted
that continuous individualized monitoring has the potential
to be useful in identifying the progression or regression of a
disease process and “could be a valuable addition to current
physiologic based monitoring systems.”Acknowledgments
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